Spinoff Licensed to Develop Alzheimer's Treatment
Thursday, September 22, 2011 - 12:00
in Health & Medicine
University of Kentucky spinoff company CoPlex Therapeutics has announced a global license with Hawthorn Pharmaceuticals to develop a treatment for Alzheimer's disease.